_http://www.rttnews.com/Content/BiotechStory.aspx?Id=1699348&Category=FDAPan
el_ 
(http://www.rttnews.com/Content/BiotechStory.aspx?Id=1699348&Category=FDAPanel) 
 
(RTTNews) - Allergan Inc. (AGN: _News _ 
(http://www.rttnews.com/SymbolSearch.aspx?Symbol=AGN) ), said Wednesday the FDA 
has approved Botox for the 
treatment of urinary  incontinence due to bladder muscle over-activity 
associated with a neurologic  condition. The approval marks the seventh medical 
use 
of Botox in the United  States market. 
Allergan said urinary incontinence (bladder leakage) due to detrusor 
(bladder  muscle) over-activity in patients with MS or SCI is a chronic 
condition  
affecting approximately 340,000 people in the United States.  

People living with MS develop lesions on the spinal cord, while  people who 
sustain a spinal cord injury have irreversible nerve damage,  resulting in 
the inability of the spinal cord and bladder to communicate  effectively.  
As a result, the bladder muscle involuntarily contracts, increasing the  
pressure in the bladder and decreasing the volume of urine the bladder can 
hold,  which causes the individual to leak urine frequently and  unexpectedly.
 
I keep some  people's phone numbers in my phone just so I  know not to 
answer when they  call.
_Daveoconnell.com  

 
In a message dated 8/24/2011 2:02:11 P.M. US Mountain Standard Time,  
[email protected] writes:

 
Anybody know how it helps?
Derrick W

FDA  OKs Botox For Urinary Trouble
Allergan Inc.'s (AGN) Botox  drug received Food and Drug Administration 
approval to treat urinary  incontinence in patients with neurologic conditions 
such as spinal-cord injury  and multiple sclerosis. 
The wrinkle-fighting drug has  FDA approval for cosmetic use and for 
treating various medical issues.  Allergan last year won approval to sell the 
drug 
as a treatment for chronic  migraine headaches. 
The company recently received  a positive opinion from Irish regulators 
regarding the use of Botox for  incontinence related to neurologic issues, 
which the company has said it  considers important to winning approval in 14 
European 


_ (http://daveoconnell.com/) 

Reply via email to